What is the most likely finding in a patient with nephrogenic diabetes insipidus (NDI) and a history of chronic lithium use presenting with dehydration and hypernatremia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Diagnostic Finding in Lithium-Induced Nephrogenic Diabetes Insipidus

The correct answer is D: Failure of the kidneys to respond to desmopressin. This is the pathognomonic finding in nephrogenic diabetes insipidus (NDI), which distinguishes it from central diabetes insipidus 1.

Pathophysiology of Lithium-Induced NDI

Nephrogenic diabetes insipidus is characterized by insensitivity of the distal nephron to arginine vasopressin (antidiuretic hormone), resulting in the kidney's inability to concentrate urine despite normal or elevated vasopressin levels 2. Chronic lithium therapy is associated with diminution of renal concentrating ability, occasionally presenting as nephrogenic diabetes insipidus with polyuria and polydipsia 3.

Why Each Answer is Correct or Incorrect

Option D (Correct): Failure to Respond to Desmopressin

  • Response to desmopressin administration is the key diagnostic test: NDI patients show minimal or no response (typically <50% increase in urine osmolality), while central diabetes insipidus patients show a positive response 1.
  • Patients with NDI will show little or no increase in urine osmolality when administered aqueous vasopressin or desmopressin, confirming renal unresponsiveness 4.
  • This distinguishes NDI from central diabetes insipidus, where desmopressin effectively increases urine concentration 1.

Option A (Incorrect): High Urine Osmolality Despite Polyuria

  • The opposite is true in NDI: patients have inappropriately dilute urine (typically <200 mOsm/kg H₂O) despite polyuria 2.
  • The diagnosis of NDI is based on demonstrating inappropriately dilute urine in the presence of normal or elevated serum osmolality 2.
  • Patients with NDI will have a urinary osmolality of less than 300 mOsm/kg H₂O despite water deprivation 4.

Option B (Incorrect): Normal or Low Plasma Osmolality

  • NDI patients typically present with elevated plasma osmolality and hypernatremia when decompensated, as in this clinical scenario 2.
  • The typical emergency in NDI is hypernatremic dehydration because of excessive water loss and/or inability to maintain adequate fluid intake 5.
  • Both NDI and central diabetes insipidus present with increased plasma osmolality 1.

Option C (Incorrect): Decreased Urine Output with Elevated Sodium Levels

  • NDI is characterized by polyuria (increased urine output), not decreased urine output 2.
  • The hallmark symptoms of NDI include polyuria and polydipsia, which develop as compensatory mechanisms 2.
  • Patients with NDI typically have urine volumes that can exceed 4 L/day 6.

Clinical Context of This Patient

This patient with chronic lithium use presenting with dehydration and hypernatremia represents a decompensated state where the normal compensatory mechanism (polydipsia) has failed 7. Lithium-induced NDI affects approximately 10% of patients treated long-term (≥15 years) and may be only partly reversible upon lithium discontinuation 6. The condition can persist for years even after lithium cessation 8.

Important Clinical Caveat

While nephrogenic diabetes insipidus is the most common form of diabetes insipidus associated with lithium use, rare cases of central diabetes insipidus have been documented with chronic lithium therapy 9. However, given the clinical presentation and the question stem specifically stating "nephrogenic diabetes insipidus," the failure to respond to desmopressin remains the defining diagnostic feature 1, 4.

References

Guideline

Diagnostic Differences Between Nephrogenic and Central Diabetes Insipidus

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Nephrogenic Diabetes Insipidus Management and Presentation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Acquired nephrogenic diabetes insipidus.

Seminars in nephrology, 2006

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.